VAD and similar alternate regimens | Download Table
Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis - ScienceDirect
Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study | BMJ Open
Treatment of relapsed and refractory multiple myeloma | Haematologica
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
Hemato | Free Full-Text | Why Immunotherapy Fails in Multiple Myeloma
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study - Yimer - 2019 - British Journal of Haematology - Wiley Online Library
3630-Multiple myeloma DVd (daratumumab bortezomib dexamethasone) overview | eviQ
Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study - ScienceDirect
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients | British Journal of Cancer
Pharmaceuticals | Free Full-Text | Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US | SpringerLink
Cancers | Free Full-Text | Recent Advances in the Treatment of Patients with Multiple Myeloma
SYNOPSIS
Approved for use in:
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma - eBioMedicine
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
Multiple Myeloma - Oncologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.
DVdSC (weekly cycles1-8) Bortezomib-Daratumumab-Dexamethasone Ver1
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
Overall survival in a cohort of multiple myeloma patients treated with... | Download Scientific Diagram
